Concepts (165)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitochondria | 3 | 2018 | 454 | 0.900 |
Why?
|
| Chlorides | 2 | 2013 | 52 | 0.870 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2021 | 35 | 0.800 |
Why?
|
| Kidney Neoplasms | 1 | 2021 | 65 | 0.780 |
Why?
|
| Prostatic Neoplasms | 4 | 2018 | 794 | 0.760 |
Why?
|
| Repressor Proteins | 1 | 2021 | 226 | 0.690 |
Why?
|
| DNA, Mitochondrial | 1 | 2018 | 165 | 0.630 |
Why?
|
| Oxidative Stress | 3 | 2013 | 874 | 0.620 |
Why?
|
| Manganese Compounds | 2 | 2013 | 12 | 0.540 |
Why?
|
| Neuroprotective Agents | 2 | 2017 | 231 | 0.500 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2014 | 28 | 0.500 |
Why?
|
| Manganese Poisoning | 1 | 2013 | 11 | 0.460 |
Why?
|
| DNA Breaks, Single-Stranded | 1 | 2013 | 12 | 0.460 |
Why?
|
| Proteome | 1 | 2014 | 132 | 0.460 |
Why?
|
| Estradiol | 1 | 2014 | 244 | 0.440 |
Why?
|
| Acetylcysteine | 1 | 2013 | 58 | 0.430 |
Why?
|
| Glutathione | 1 | 2013 | 160 | 0.420 |
Why?
|
| Proteomics | 1 | 2014 | 302 | 0.420 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 298 | 0.390 |
Why?
|
| Antioxidants | 2 | 2013 | 386 | 0.380 |
Why?
|
| Cell Survival | 6 | 2015 | 818 | 0.330 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2015 | 984 | 0.310 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 968 | 0.310 |
Why?
|
| Neurons | 1 | 2013 | 1130 | 0.270 |
Why?
|
| Microglia | 2 | 2018 | 152 | 0.270 |
Why?
|
| Manganese | 2 | 2017 | 59 | 0.270 |
Why?
|
| Databases, Genetic | 1 | 2021 | 90 | 0.200 |
Why?
|
| Cell Line, Tumor | 5 | 2017 | 2128 | 0.190 |
Why?
|
| Survival Rate | 1 | 2021 | 310 | 0.190 |
Why?
|
| Lipopolysaccharides | 2 | 2018 | 200 | 0.180 |
Why?
|
| Prognosis | 1 | 2021 | 707 | 0.170 |
Why?
|
| Oxidative Phosphorylation | 1 | 2018 | 49 | 0.170 |
Why?
|
| Apoptosis | 2 | 2018 | 1317 | 0.170 |
Why?
|
| Hydrolyzable Tannins | 1 | 2018 | 14 | 0.170 |
Why?
|
| Male | 7 | 2021 | 18870 | 0.170 |
Why?
|
| Aggression | 1 | 2018 | 75 | 0.160 |
Why?
|
| Environment | 1 | 2018 | 130 | 0.160 |
Why?
|
| Excitatory Amino Acid Transporter 1 | 1 | 2017 | 9 | 0.160 |
Why?
|
| Butyric Acid | 1 | 2017 | 17 | 0.160 |
Why?
|
| Valproic Acid | 1 | 2017 | 14 | 0.150 |
Why?
|
| Interferon-gamma | 1 | 2018 | 235 | 0.150 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 1 | 2017 | 25 | 0.150 |
Why?
|
| Inflammation Mediators | 1 | 2018 | 120 | 0.150 |
Why?
|
| Health Status Disparities | 2 | 2014 | 583 | 0.150 |
Why?
|
| Contrast Media | 1 | 2017 | 95 | 0.150 |
Why?
|
| Biomedical Research | 1 | 2021 | 371 | 0.150 |
Why?
|
| Humans | 9 | 2021 | 34853 | 0.150 |
Why?
|
| Liposomes | 1 | 2017 | 107 | 0.150 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 162 | 0.150 |
Why?
|
| Life Style | 1 | 2018 | 288 | 0.150 |
Why?
|
| Socioeconomic Factors | 2 | 2018 | 1003 | 0.140 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 416 | 0.140 |
Why?
|
| Pancreatic Neoplasms | 1 | 2017 | 106 | 0.140 |
Why?
|
| NF-kappa B | 1 | 2018 | 306 | 0.140 |
Why?
|
| Astrocytes | 1 | 2017 | 203 | 0.130 |
Why?
|
| Benzoquinones | 1 | 2015 | 34 | 0.130 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 2333 | 0.130 |
Why?
|
| Young Adult | 3 | 2021 | 4012 | 0.130 |
Why?
|
| Motor Activity | 1 | 2017 | 393 | 0.130 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 468 | 0.120 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2012 | 790 | 0.120 |
Why?
|
| Disease | 1 | 2013 | 18 | 0.120 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 137 | 0.120 |
Why?
|
| Testosterone | 1 | 2014 | 181 | 0.120 |
Why?
|
| Genetic Markers | 1 | 2013 | 118 | 0.120 |
Why?
|
| Hydrogen Peroxide | 2 | 2012 | 181 | 0.110 |
Why?
|
| Thymine | 1 | 2013 | 25 | 0.110 |
Why?
|
| Comet Assay | 1 | 2013 | 72 | 0.110 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2013 | 75 | 0.110 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2013 | 126 | 0.110 |
Why?
|
| DNA Repair | 1 | 2013 | 181 | 0.110 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2013 | 193 | 0.110 |
Why?
|
| Heme Oxygenase-1 | 1 | 2012 | 46 | 0.110 |
Why?
|
| PC12 Cells | 1 | 2012 | 84 | 0.110 |
Why?
|
| Education, Pharmacy | 1 | 2012 | 32 | 0.100 |
Why?
|
| Neoplasms | 1 | 2021 | 1033 | 0.100 |
Why?
|
| Flow Cytometry | 1 | 2013 | 392 | 0.100 |
Why?
|
| Students, Pharmacy | 1 | 2012 | 37 | 0.100 |
Why?
|
| Lactic Acid | 1 | 2012 | 87 | 0.100 |
Why?
|
| Aged | 2 | 2021 | 6448 | 0.100 |
Why?
|
| RNA, Messenger | 2 | 2015 | 1152 | 0.100 |
Why?
|
| Clinical Competence | 1 | 2012 | 124 | 0.100 |
Why?
|
| Cultural Competency | 1 | 2012 | 120 | 0.100 |
Why?
|
| Adult | 4 | 2021 | 11034 | 0.100 |
Why?
|
| Middle Aged | 3 | 2021 | 9642 | 0.100 |
Why?
|
| Glucose | 1 | 2012 | 217 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 756 | 0.090 |
Why?
|
| Animals | 7 | 2018 | 14307 | 0.090 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2012 | 406 | 0.090 |
Why?
|
| Cell Proliferation | 1 | 2014 | 1149 | 0.080 |
Why?
|
| Gene Expression | 1 | 2012 | 639 | 0.080 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 600 | 0.080 |
Why?
|
| Oxidopamine | 2 | 2005 | 18 | 0.080 |
Why?
|
| Time Factors | 1 | 2012 | 1681 | 0.080 |
Why?
|
| Rats | 2 | 2012 | 3261 | 0.070 |
Why?
|
| Female | 3 | 2021 | 19873 | 0.070 |
Why?
|
| Florida | 2 | 2021 | 358 | 0.070 |
Why?
|
| Neurotoxins | 1 | 2005 | 52 | 0.060 |
Why?
|
| Smoke | 1 | 2005 | 39 | 0.060 |
Why?
|
| Health Behavior | 1 | 2008 | 491 | 0.060 |
Why?
|
| Nitric Oxide Synthase | 1 | 2005 | 103 | 0.060 |
Why?
|
| Neuroglia | 1 | 2005 | 117 | 0.060 |
Why?
|
| Glycolysis | 1 | 2004 | 66 | 0.060 |
Why?
|
| Nitrites | 2 | 2015 | 38 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2015 | 91 | 0.050 |
Why?
|
| Mice | 3 | 2018 | 5668 | 0.040 |
Why?
|
| Smoking | 1 | 2005 | 903 | 0.040 |
Why?
|
| Phantoms, Imaging | 1 | 2017 | 22 | 0.040 |
Why?
|
| Viscosity | 1 | 2017 | 37 | 0.040 |
Why?
|
| Gadolinium | 1 | 2017 | 27 | 0.040 |
Why?
|
| Deoxycytidine | 1 | 2017 | 21 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2017 | 91 | 0.040 |
Why?
|
| Rotarod Performance Test | 1 | 2017 | 13 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2017 | 114 | 0.040 |
Why?
|
| Cerebellum | 1 | 2017 | 69 | 0.040 |
Why?
|
| Hot Temperature | 1 | 2017 | 120 | 0.040 |
Why?
|
| Particle Size | 1 | 2017 | 200 | 0.040 |
Why?
|
| Students | 1 | 2021 | 452 | 0.040 |
Why?
|
| Minority Groups | 1 | 2021 | 537 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2017 | 323 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2017 | 182 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2015 | 87 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2017 | 274 | 0.030 |
Why?
|
| Lysine | 1 | 2015 | 104 | 0.030 |
Why?
|
| Cell Line | 1 | 2018 | 1289 | 0.030 |
Why?
|
| Hormone Replacement Therapy | 1 | 2014 | 41 | 0.030 |
Why?
|
| Models, Biological | 1 | 2017 | 642 | 0.030 |
Why?
|
| Age Distribution | 1 | 2014 | 223 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 445 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2015 | 396 | 0.030 |
Why?
|
| Nanoparticles | 1 | 2017 | 294 | 0.030 |
Why?
|
| Magnesium | 1 | 2013 | 95 | 0.030 |
Why?
|
| Cross-Sectional Studies | 2 | 2012 | 2561 | 0.030 |
Why?
|
| Health Surveys | 1 | 2014 | 358 | 0.030 |
Why?
|
| Alleles | 1 | 2013 | 284 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 1530 | 0.030 |
Why?
|
| Schools, Pharmacy | 1 | 2012 | 13 | 0.030 |
Why?
|
| Professional-Patient Relations | 1 | 2012 | 44 | 0.030 |
Why?
|
| United States | 2 | 2014 | 3894 | 0.030 |
Why?
|
| Awareness | 1 | 2012 | 59 | 0.030 |
Why?
|
| Cytokines | 1 | 2015 | 569 | 0.030 |
Why?
|
| Cultural Characteristics | 1 | 2012 | 119 | 0.030 |
Why?
|
| Prejudice | 1 | 2012 | 101 | 0.030 |
Why?
|
| Phenotype | 1 | 2013 | 650 | 0.020 |
Why?
|
| Cultural Diversity | 1 | 2012 | 158 | 0.020 |
Why?
|
| Language | 1 | 2012 | 143 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2012 | 186 | 0.020 |
Why?
|
| Curriculum | 1 | 2012 | 237 | 0.020 |
Why?
|
| Mutation | 1 | 2013 | 1023 | 0.020 |
Why?
|
| Nigeria | 1 | 2008 | 74 | 0.020 |
Why?
|
| Emigrants and Immigrants | 1 | 2008 | 125 | 0.020 |
Why?
|
| Child | 1 | 2014 | 2875 | 0.020 |
Why?
|
| Sympatholytics | 1 | 2005 | 13 | 0.020 |
Why?
|
| Pyridinium Compounds | 1 | 2005 | 21 | 0.020 |
Why?
|
| Oxidants | 1 | 2005 | 43 | 0.020 |
Why?
|
| Mass Screening | 1 | 2008 | 427 | 0.020 |
Why?
|
| Monoamine Oxidase | 1 | 2005 | 31 | 0.020 |
Why?
|
| Cell Respiration | 1 | 2004 | 33 | 0.020 |
Why?
|
| Glioma | 1 | 2005 | 76 | 0.020 |
Why?
|
| Neuroblastoma | 1 | 2005 | 128 | 0.020 |
Why?
|
| Adolescent | 1 | 2014 | 5035 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2004 | 407 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2005 | 287 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2005 | 834 | 0.010 |
Why?
|
| Risk Factors | 1 | 2008 | 3414 | 0.010 |
Why?
|